In the context of Chimeric Antigen Receptors (CAR) and Tumor-infiltrating lymphocytes (TIL) therapy, a study unveiled that the different intensities of CD26 expression identified three distinct human T CD4+ helper cells: regulatory, naive, and stem memory, with varying levels of anti-tumor activity [14]. The gene discussed is CD4; the disease is neoplasm.